Home Other Building Blocks 1H-Indole-3-ethanamine, α-methyl-5-(2-thienylmethoxy)-, hydrochloride (1:1)

1H-Indole-3-ethanamine, α-methyl-5-(2-thienylmethoxy)-, hydrochloride (1:1)

CAS No.:
160521-72-2
Catalog Number:
AG001S07
Molecular Formula:
C16H19ClN2OS
Molecular Weight:
322.8529
Pack Size
Purity
Availability
Location
Price(USD)
Quantity
  
1mg
≥98%
1 week
United States
$75
- +
5mg
≥98%
1 week
United States
$139
- +
10mg
≥98%
1 week
United States
$201
- +
50mg
≥98%
1 week
United States
$689
- +
Product Description
Catalog Number:
AG001S07
Chemical Name:
1H-Indole-3-ethanamine, α-methyl-5-(2-thienylmethoxy)-, hydrochloride (1:1)
CAS Number:
160521-72-2
Molecular Formula:
C16H19ClN2OS
Molecular Weight:
322.8529
MDL Number:
MFCD01321066
IUPAC Name:
1-[5-(thiophen-2-ylmethoxy)-1H-indol-3-yl]propan-2-amine;hydrochloride
InChI:
InChI=1S/C16H18N2OS.ClH/c1-11(17)7-12-9-18-16-5-4-13(8-15(12)16)19-10-14-3-2-6-20-14;/h2-6,8-9,11,18H,7,10,17H2,1H3;1H
InChI Key:
PYJBJMIBANAOFJ-UHFFFAOYSA-N
SMILES:
CC(Cc1c[nH]c2c1cc(OCc1cccs1)cc2)N.Cl
Properties
Complexity:
315  
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
2  
Defined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
0
Exact Mass:
322.091g/mol
Formal Charge:
0
Heavy Atom Count:
21  
Hydrogen Bond Acceptor Count:
3  
Hydrogen Bond Donor Count:
3  
Isotope Atom Count:
0
Molecular Weight:
322.851g/mol
Monoisotopic Mass:
322.091g/mol
Rotatable Bond Count:
5  
Topological Polar Surface Area:
79.3A^2
Undefined Atom Stereocenter Count:
1  
Undefined Bond Stereocenter Count:
0
Literature
Title Journal
BF-1--a novel selective 5-HT2B receptor antagonist blocking neurogenic dural plasma protein extravasation in guinea pigs. European journal of pharmacology 20150315
Serotonin-induced brain glycogenolysis in rainbow trout (Oncorhynchus mykiss). The Journal of experimental biology 20120901
Antinociceptive effect of peripheral serotonin 5-HT2B receptor activation on neuropathic pain. Pain 20120601
Participation of cyclooxygenase pathway in the vasoconstriction induced by 5-HT in the in situ autoperfused kidney of long-term diabetic rats. European journal of pharmacology 20110520
Serotonin 2A and 2B receptor-induced phrenic motor facilitation: differential requirement for spinal NADPH oxidase activity. Neuroscience 20110331
Evidence for noncompetitive modulation of substrate-induced serotonin release. Synapse (New York, N.Y.) 20101101
Protein kinase C{gamma} mediates regulation of proliferation by the serotonin 5-hydroxytryptamine receptor 2B. The Journal of biological chemistry 20090807
5-HT2 receptor-mediated reversal of the inhibition of hippocampal long-term potentiation by acute inescapable stress. Neuropharmacology 20080801
5HT2 receptor activation facilitates P2X receptor mediated excitatory neurotransmission to cardiac vagal neurons in the nucleus ambiguus. Neuropharmacology 20080601
Rikkunshito, an herbal medicine, suppresses cisplatin-induced anorexia in rats via 5-HT2 receptor antagonism. Gastroenterology 20080601
Exogenous serotonin regulates proliferation of interstitial cells of Cajal in mouse jejunum through 5-HT2B receptors. Gastroenterology 20070901
Activation of nucleus tractus solitarius 5-HT2A but not other 5-HT2 receptor subtypes inhibits the sympathetic activity in rats. The European journal of neuroscience 20070701
Anxiolytic-like effect of 5-HT(2) ligands and benzodiazepines co-administration: comparison of two animal models of anxiety (the four-plate test and the elevated plus maze). Behavioural brain research 20070227
Endogenous 5-HT2B receptor activation regulates neonatal respiratory activity in vitro. Journal of neurobiology 20060801
Microsphere-based protease assays and screening application for lethal factor and factor Xa. Cytometry. Part A : the journal of the International Society for Analytical Cytology 20060501
Implication of 5-HT2A subtype receptors in DOI activity in the four-plates test-retest paradigm in mice. Behavioural brain research 20060106
Contribution of serotonin (5-hydroxytryptamine; 5-HT) 5-HT2 receptor subtypes to the hyperlocomotor effects of cocaine: acute and chronic pharmacological analyses. The Journal of pharmacology and experimental therapeutics 20040901
Vasoconstrictor responses to 5-hydroxytryptamine in the autoperfused hindquarters of spontaneously hypertensive rats. Pharmacology 20040601
Antiallodynic effects of intrathecally administered 5-HT(2C) receptor agonists in rats with nerve injury. Pain 20040301
Discriminative stimulus properties of (+/-)-fenfluramine: the role of 5-HT2 receptor subtypes. Behavioral neuroscience 20030401
Anxiolytic-like effects of 5-HT2 ligands on three mouse models of anxiety. Behavioural brain research 20030318
Arterial expression of 5-HT2B and 5-HT1B receptors during development of DOCA-salt hypertension. BMC pharmacology 20030101
Alteration in 5-hydroxytryptamine agonist-induced behaviour following a corticosterone implant in adult rats. Pharmacology, biochemistry, and behavior 20020401
Serotonin-induced contraction in mesenteric resistance arteries: signaling and changes in deoxycorticosterone acetate-salt hypertension. Hypertension (Dallas, Tex. : 1979) 20020301
Investigations into migraine pathogenesis: time course for effects of m-CPP, BW723C86 or glyceryl trinitrate on appearance of Fos-like immunoreactivity in rat trigeminal nucleus caudalis (TNC). Cephalalgia : an international journal of headache 20010201
Properties